Rona Therapeutics Signs Global License Agreement With Roche
Rona Therapeutics entered a global license agreement with Roche for an ALK7-targeting RNAi therapy for obesity and metabolic diseases.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.